Aseem Anand

High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants

Pedram Razavi, Bob T. Li, David N. Brown et al. · Nature Medicine · 2019 · 718 citations · Full text

Dna Sequencing, Sequencing, High-intensity Sequencing +12

TMPRSS2-ERG Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate

Daniel C. Danila, Aseem Anand, Clifford C. Sung et al. · European Urology · 2011 · 191 citations · Full text

Tmprss2-erg Status, Prognostic Biomarkers, Urology +12

Evaluation of circulating tumor cell (CTC) enumeration as an efficacy response biomarker of overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC): Planned final analysis (FA) of COU-AA-301, a randomized, double-blind, placebo-controlled, phase III study of abiraterone acetate (AA) plus low-dose prednisone (P) post docetaxel.

Howard I. Scher, Glenn Heller, Ana M. Molina et al. · Journal of Clinical Oncology · 2011 · 113 citations

Ctc Counts, Cancer Management, Gynecology +18

Phase 3 Assessment of the Automated Bone Scan Index as a Prognostic Imaging Biomarker of Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer

Andrew J. Armstrong, Aseem Anand, Lars Edenbrandt et al. · JAMA Oncology · 2018 · 100 citations · Full text

Clinical Validity of Detecting Circulating Tumor Cells by AdnaTest Assay Compared With Direct Detection of Tumor mRNA in Stabilized Whole Blood, as a Biomarker Predicting Overall Survival for Metastatic Castration-Resistant Prostate Cancer Patients

Daniel C. Danila, Aliaksandra Samoila, Chintan Patel et al. · The Cancer Journal · 2016 · 78 citations

Circulating Tumor Cells, Pathology, Tumor Biology +17